Yannick Brunet, PhD

Associate, Infectious Disease

Yannick Brunet is a Healthcare Associate with the TechAtlas team at RA Capital Management. Yannick’s primary responsibilities are to work closely with members of the investment team to deeply understand competitive landscapes, evaluate investment opportunities, and advise portfolio companies on program and pipeline strategy. Prior to RA Capital, Yannick most recently served as Head of Synthetic Biology at Robigo where he directed a lean, agile team to drive the development of a novel RNAi-based antifungal modality. Yannick holds a PhD in Biology from Aix-Marseille University.